Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

Next In Business News

Weak undertones on Bursa as Fed decision looms
Ringgit slips vs US$, rises against majors on Fed cut expectations
Fed chair front-runner Hassett says 'plenty of room' to cut rates
Trading ideas: TNB, Zetrix AI, Matrix, Southern Score, DKSH, Perak Transit, FBG, AWC, TechStore, Jentayu, PJBumi, One Gasmaster
S&P 500 ends down as investors await Fed rate decision
FBG wins RM206mil building job
DKSH to take DHMB private for RM6.15 per share
Hong Kong banks call for IPOs to maintain key standards
Matrix Concepts disposes of land for RM25mil
France�drawing up plans to shield food output

Others Also Read